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Introduction
Dendritic spines are small, actin-rich protrusions scattered 
along dendrites, and they carry the postsynaptic components 
of >90% of excitatory synapses. Despite of being tiny in size, 
spines are highly dynamic structures that continuously undergo 
changes in shape and size over time (Hering and Sheng, 2001; 
Yuste and Bonhoeffer, 2004). A multitude of molecules has 
been implicated in dendritic spine development and remodel-
ing. Among these, the neurotransmitter receptors, especially 
N-methyl-d-  aspartic acid (NMDA) receptor (NR) and α-amino-
3-hydroxy-5-methylisoxazole-propionic acid (AMPA) receptor 
(GluR), which are well-known inducers of spine formation, reg-
ulate spine maturation and stabilization via calcium-dependent 
regulation of fi  lamentous actin turnover (Matus, 2000; Oertner 
and Matus, 2005). Besides, other cell surface molecules also 
infl  uence spine properties in response to external signals by 
mediating cell adhesion and regulating the networks of inter-
connected signaling pathways, which converge to regulate 
actin dynamics in spines (Ethell and Pasquale, 2005; Tada and 
Sheng, 2006).
Cell adhesion molecules (CAMs) and ECM molecules are 
instrumental in providing physical connections and generating 
cellular signaling events. Importantly, several recent studies 
have suggested the involvement of CAMs and ECMs in dendritic 
spine remodeling (Ethell and Pasquale, 2005) and synaptic plas-
ticity (Washbourne et al., 2004; Gerrow and El-Husseini, 2006). 
These include N-cadherin (Togashi et al., 2002), syndecan-2 
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atrix metalloproteinase (MMP)-2 and -9 are 
pivotal in remodeling many tissues. However, 
their functions and candidate substrates for 
brain development are poorly characterized. Intercellular 
adhesion molecule-5 (ICAM-5; Telencephalin) is a neuro-
nal adhesion molecule that regulates dendritic elongation 
and spine maturation. We ﬁ  nd that ICAM-5 is cleaved 
from hippocampal neurons when the cells are treated with 
N-methyl-D-aspartic acid (NMDA) or α-amino-3-hydroxy-
5-methylisoxazole-propionic acid (AMPA). The cleavage is 
blocked by MMP-2 and -9 inhibitors and small interfering 
RNAs. Newborn MMP-2– and MMP-9–deﬁ  cient mice 
brains contain more full-length ICAM-5 than wild-type 
mice. NMDA receptor activation disrupts the actin cyto-
skeletal association of ICAM-5, which promotes its cleav-
age. ICAM-5 is mainly located in dendritic ﬁ  lopodia and 
immature thin spines. MMP inhibitors block the NMDA-
induced cleavage of ICAM-5 more efﬁ  ciently in dendritic 
shafts than in thin spines. ICAM-5 deﬁ  ciency causes re-
traction of thin spine heads in response to NMDA stimula-
tion. Soluble ICAM-5 promotes elongation of dendritic 
ﬁ  lopodia from wild-type neurons, but not from ICAM-5–
deﬁ  cient neurons. Thus, MMPs are important for ICAM-5–
mediated dendritic spine development.
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(Ethell et al., 2001), neural CAM (Dityatev et al., 2004), integ-
rins (Shi and Ethell, 2006), laminins (Oray et al., 2004), and 
reelin (Liu et al., 2001).
Intercellular adhesion molecule-5 (ICAM-5; Telencephalin) 
belongs to the Ig superfamily (Yoshihara et al., 1994; Gahmberg 
et al., 1998). It is specifi  cally expressed in the postnatal excitatory 
neuronal cell bodies, dendritic shafts, and dendritic fi  lopodia of 
the telencephalon (Benson et al., 1998; Mitsui et al., 2005). The 
expression of ICAM-5 temporally parallels dendritogenesis and 
synaptogenesis (Yoshihara et al., 1994). In agreement, ICAM-5 
has been shown to promote dendritic elongation and branching 
of hippocampal neurons in vitro (Tian et al., 2000). ICAM-5–
defi  cient mice exhibited decreased density of dendritic fi  lopodia, 
accelerated maturation of dendritic spines (Matsuno et al., 2006), 
and changes in long-term potentiation (LTP) in the hippocampus 
(Nakamura et al., 2001).
Soluble ICAM-5 (sICAM-5) has been detected in physio-
logical fl  uids under several pathological conditions (Guo et al., 
2000; Lindsberg et al., 2002; Borusiak et al., 2005). However, 
the nature of candidate proteinases and the physiological mean-
ing of the proteolytic cleavage of membrane-bound ICAM-5 
have remained unknown.
Matrix metalloproteinases (MMPs) form a large family 
of mostly secreted, zinc-dependent endopeptidases, which are 
important for the regulation of cellular behavior through pro-
teolytic cleavage of ECMs and cell surface proteins (Malemud, 
2006). Although a large body of data has connected MMPs 
to brain injury and pathology, accumulating evidence has 
extended their roles into the normal physiological functions 
of the brain (Dzwonek et al., 2004; Luo, 2005; Ethell and 
Ethell, 2007).
Among MMPs, MMP-2 and -9 are most abundantly ex-
pressed in the developing brain. MMP-2 is found mainly in as-
trocytes, whereas MMP-9 is highly expressed in neuronal cell 
bodies and dendrites (Szklarczyk et al., 2002; Ayoub et al., 
2005). The expression and activity of MMP-9 have been shown 
to depend on NR activation and LTP (Meighan et al., 2006; 
Nagy et al., 2006). Growing data also suggest the association of 
MMP-9 (Meighan et al., 2006; Nagy et al., 2006) and other 
ECM-degrading enzymes (Oray et al., 2004; Bilousova et al., 
2006; Monea et al., 2006) with dendritic spine remodeling, syn-
aptic plasticity, learning, and memory formation. Although sev-
eral ECMs and cell surface proteins, which play important roles 
in the aforementioned functions, have been identifi  ed as MMP 
substrates, the target molecules for MMP-2 or -9 in the brain 
have remained largely elusive.
In the present study, we examined the possibility of ICAM-5 
acting as a substrate for MMP-2 or -9, using a variety of experi-
mental approaches, and investigated the role of MMP-mediated 
ICAM-5 proteolytic cleavage in the regulation of dendritic 
spine development.
Results
NMDA and AMPA promote cleavage 
of ICAM-5 from hippocampal neurons
Because sICAM-5 has been detected under various pathologi-
cal conditions, we studied whether ICAM-5 cleavage takes 
place during physiological neuronal maturation. For this pur-
pose, we examined the release of sICAM-5 from cultured hip-
pocampal neurons at different developmental stages in vitro 
(3–21 d in vitro [DIV]). The expression of full-length ICAM-5 
of 130 kD was low in the 3-DIV hippocampal neurons, but 
starting from 7 DIV, when dendrites extensively develop in hip-
pocampal neurons, the expression of full-length ICAM-5 dra-
matically increased and reached a plateau thereafter (Fig. 1, 
A and B, right). In comparison with this, sICAM-5 of 85–110 kD 
was most strongly released at 14–21 DIV (Fig. 1, A and B, 
left), which parallels the period of dendritic spine maturation 
and synaptic formation. This indicates that the cleavage of 
membrane-bound ICAM-5 may play an important role during 
spine maturation.
Figure 1.  Cleavage of ICAM-5 from hippo-
campal neurons is promoted by NMDA and 
AMPA. (A) Cell lysates and culture media from 
rat primary hippocampal neurons of different 
developmental stages (3–21 DIV) were collected 
separately, and ICAM-5 was detected by poly-
clonal antibodies against the ICAM-5 cytoplas-
mic tail (ICAM-5cp) or ectodomains (1000J), 
respectively. sICAM-5 of 85- and 110-kD frag-
ments were released into the media and reached 
a maximum at 14–21 DIV, whereas the expres-
sion of full-length ICAM-5 of 130 kD in neurons 
started to increase from 7 DIV onward. (B) Quan-
titative analysis of band intensities. (C) In 14-DIV 
hippocampal neurons, 5 μM NMDA or AMPA 
treatment caused a signiﬁ   cant release of the 
sICAM-5 fragments with a concomitant reduction 
of the membrane-bound ICAM-5-ﬂ   level, which 
was inhibited by 20 μM of their respective 
antagonists, MK801 or DNQX. Half of each 
medium sample was applied to SDS-PAGE gel 
for analysis. (D) Quantitative analysis of band 
intensities of the sICAM-5110 from the culture 
media. Error bars indicate mean ± SD. *, P < 
0.05; **, P < 0.01.ICAM-5 CLEAVAGE BY MMPS REGULATES SPINE DEVELOPMENT • TIAN ET AL. 689
The NRs and GluRs are key regulators of spine formation 
and maturation. Therefore, we tested the effects of NMDA and 
AMPA on ICAM-5 cleavage from hippocampal neurons. In 14-
DIV hippocampal neurons, 5 μM NMDA or AMPA treatment 
caused signifi  cant release of the sICAM-5 fragments of 110 and 
80–85 kD, with concomitant reduction of the membrane-bound 
ICAM-5 (Fig. 1, C and D). Moreover, the cleavage of ICAM-5 
was inhibited by the NMDA antagonist MK801 and the non-
NMDA antagonist DNQX (6,7,-dinitroquinoxaline-2,3[1H,4H]-
dione; Fig. 1, C and D).
MMP-2 and -9 cleave 
the membrane-bound ICAM-5
To further investigate the mechanism of ICAM-5 proteo-
lytic cleavage, we used various chemical or peptide inhib-
itors of MMPs. As shown in Fig. 2, ICAM-5 cleavage was 
almost completely inhibited by the broad-spectrum MMP in-
hibitor GM6001, but not by its negative control. A variety of 
MMP-2 and -9 inhibitors also partially or completely blocked 
the cleavage (Fig. 2, A and B). These data provide the fi  rst 
evidence that MMP-2 and -9, especially when activated by 
Figure 2.  Cleavage of ICAM-5 is mediated by MMP-2 and -9. (A) 14-DIV neurons were left untreated or treated with NMDA in the presence of MMP inhibi-
tors. The NMDA-induced cleavage of ICAM-5 was blocked by MMP-2 and -9 inhibitors, as compared with the negative controls. Actin in cell lysates was 
used to quantitate the amount of cells from which the culture media were collected. (B) Quantitative analysis of A. Error bars indicate mean ± SD. *, P < 
0.05; **, P <0.01. (C) The siRNAs for rat MMP-2 and -9 transfected into the 9-DIV neurons efﬁ  ciently blocked the ICAM-5 cleavage. Incubation of recom-
binant mouse ICAM-5 D1-9-Fc protein with active MMP-2 or -9 enzyme resulted in cleavage of the recombinant protein into multiple fragments, as detected 
by anti–ICAM-5 (D) or anti-Fc antibody (E). Interestingly, the two MMPs seemed to prefer different cleavage sites, although both cleave ICAM-5 in a similar 
way, as depicted in F. The indicated cleaved fragments (CTF130, NTF80, and NTF40) were analyzed by mass spectrometry peptide mapping.JCB • VOLUME 178 • NUMBER 4 • 2007  690
NMDA, are mainly responsible for the proteolytic cleavage 
of ICAM-5.
Because the expression and activity of MMP-9 have been 
shown to be up-regulated in response to stimuli that induce NR 
activation and LTP (Meighan et al., 2006; Nagy et al., 2006), we 
tested the conditioned culture media from treated hippocampal 
neurons and found increased levels of both active MMP-2 and -9 
upon NMDA stimulation (Fig. S1, available at http://www
.jcb.org/cgi/content/full/jcb.200612097/DC1). We then used the 
RNA interference technique to temporarily decrease the expres-
sion of MMP-2 or -9 in hippocampal neurons (Fig. 2 C). After 
transfection into neurons, the MMP-2 and -9 siRNAs substan-
tially decreased the protein levels of MMP-2 and -9, respectively 
(Fig. 2 C, right), with the concomitant inhibition of ICAM-5 
cleavage from the transfected neurons (Fig. 2 C, left).
We further incubated the recombinant mouse ICAM-5 D1-
9-Fc protein with activated MMP-2 or -9 and studied the cleav-
age using anti–ICAM-5 polyclonal antibody 1000J (Fig. 2 D) 
or anti-Fc polyclonal antibody (Fig. 2 E) in Western blots. The 
cleaved proteins were then analyzed by matrix-assisted laser 
desorption/ionization–time of fl  ight (MALDI-TOF) peptide mass 
mapping to identify the individual fragments (C-terminal frag-
ment [CTF] 130-Fc, N-terminal fragment [NTF] 80–85, and 
NTF40; Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200612097/DC1). We found that both MMP-2 and -9 cut 
at similar sites in the second and ninth ectodomains of ICAM-5, 
as depicted in Fig. 2 F. Interestingly, they seemed to show selec-
tivity for the cleavage sites, as shown by the intensities of the 
fragments they produced. The minor bands detected within 30–75 
kD in Fig. 2 (D and E) may be caused by protein degradation.
Dissociation of ICAM-5 from the 
cytoskeleton promotes its cleavage
Because the NRs and GluRs are known to regulate actin dynam-
ics, we examined whether the NR-promoted cleavage of ICAM-5 
is dependent on its anchorage to actin fi  laments. Interestingly, 
we found that cytochalasin D and latrunculin A, which prevent 
actin polymerization by capping the barbed end of actin fi  la-
ments and monomeric actin, respectively, signifi  cantly increased 
the cleavage of ICAM-5 (Fig. 3, A and B). This indicates that 
the association between ICAM-5 and actin fi  laments may af-
fect the MMP-mediated proteolytic cleavage. Furthermore, we 
found that treatment of hippocampal neurons with 20 μM NMDA 
for 1 h resulted in a considerable release of ICAM-5 from the 
cytoskeletal fraction into the soluble fraction of neuronal lysates 
(Fig. 3, C and D). These fi  ndings strongly support the hypothesis 
that dissociation of ICAM-5 from the actin cytoskeleton pro-
motes its cleavage.
Figure 3.  Dissociation of ICAM-5 from the 
actin cytoskeleton promotes its cleavage. 14-DIV 
neurons were left untreated or treated with cy-
tochalasin D or latrunculin A. The results from 
Western blotting (A) and quantitative analysis 
of the band intensities (B) showed that both 
cytochalasin D and latrunculin A strongly in-
creased the cleavage of ICAM-5. Furthermore, 
14-DIV neurons were treated with 20 μM 
NMDA for 60 min before being lysed, and the 
lysates were then separated by ultracentrifuga-
tion into soluble fractions, which contain dis-
solved membrane proteins and soluble cytosolic 
proteins, and cytoskeletal fractions, which con-
tain the majority of actin ﬁ  laments. Detection 
of ICAM-5 and actin showed dissociation of 
ICAM-5 from the actin cytoskeleton after NMDA 
treatment (C). (D) ICAM-5 levels in the soluble 
and cytoskeletal fractions were quantiﬁ   ed. 
Moreover, the transfected neural crest cell 
lines, Paju-ICAM-5-ﬂ    and Paju-ICAM-5-∆CP, 
which expressed full-length or cytoplasmic tail-
truncated ICAM-5, respectively, were analyzed 
(E and F). Schematic drawings of the two 
ICAM-5 constructs are shown. Paju-ICAM-5-∆CP 
cells released a considerably larger amount of 
the sICAM-5 than Paju-ICAM-5-ﬂ   cells (E and F). 
Quantitation of actin was done as described 
in Fig. 2 A. Error bars indicate mean ± SD. 
*, P < 0.05.ICAM-5 CLEAVAGE BY MMPS REGULATES SPINE DEVELOPMENT • TIAN ET AL. 691
To further study this phenomenon, we compared Paju-
ICAM-5-fl   and Paju-ICAM-5-∆CP cell lines, which express the 
full-length ICAM-5 or the truncated ICAM-5 without the cyto-
plasmic domain (Fig. 3 E), respectively. We have shown that 
truncation of the cytoplasmic tail of ICAM-5 results in a more 
diffuse distribution of the molecule on the plasma membrane 
and reduced colocalization with the subcortical actin fi  laments 
(Nyman-Huttunen et al., 2006). The cell surface expression level 
of ICAM-5 on both cell lines was comparable (Fig. S3, available 
at http://www.jcb.org/cgi/content/full/jcb.200612097/DC1). 
Compared with Paju-ICAM-5-fl  , Paju-ICAM-5-∆CP cells showed 
a considerable increase of ICAM-5 cleavage (Fig. 3, E and F).
Abnormal ICAM-5 expression during 
early postnatal development of MMP-2– 
and MMP-9–deﬁ  cient mice
To further clarify the involvement of MMP-2 and -9 on ICAM-5 
cleavage, we studied the expression of ICAM-5 in MMP-defi  cient 
mice at different postnatal developmental stages (from postnatal 
1 d to 10 wk). ICAM-5 expression was increased in all MMP-
defi  cient mice after birth, whereas L1CAM showed a decreased 
expression (Fig. 4, A and C). Moreover, it is noteworthy that, 
compared with the wild-type (WT) mice, the MMP-2
−/− and 
MMP-9
−/− defi   cient mice contained signifi   cantly more full-
length ICAM-5 at the early postnatal stage (postnatal day 1). 
However, the MMP-2
−/−/MMP-9
−/− double-defi  cient mice ex-
pressed lower levels of ICAM-5 (Fig. 4, A and C). The changes 
in the MMP-2
−/−, MMP-9
−/−, and MMP-2
−/−/MMP-9
−/− double-
defi  cient mice tended to disappear after 1 wk postnatally, ex-
cept in the MMP-2
−/−/MMP-9
−/− double-defi  cient mice, where 
ICAM-5 expression still remained slightly but signifi  cantly 
lower than in the WT mice (Fig. 4, A and C). Studies on the en-
zymatic activities of MMP-2 and -9 by gelatinase zymography 
verifi  ed the identity of the respective defi  cient mice (Fig. 4 B) 
and indicated that the activity of MMP-2 in both the MMP-9
−/− 
defi  cient mice and the WT mice decreased during the postnatal 
development. However, there seemed to be some compensating 
up-regulation of the proMMP-9 level in the adult MMP-2
−/− 
Figure 4.  ICAM-5 expression is abnormal 
during early postnatal development of MMP-
2– and MMP-9–deﬁ  cient mice. The forebrains 
from postnatal (1 d to 10 wk) MMP-deﬁ  cient 
and WT mice were homogenized, and the 
membrane fractions were obtained by ultra-
centrifugation. The results from Western blot-
ting (A) and quantitative analysis of the band 
intensities (C) both showed that in postnatal 1-d 
mice, the expression levels of ICAM-5 were 
signiﬁ   cantly higher in MMP-2
−/− and MMP-
9
−/− mice than in WT mice, whereas in MMP-
2
−/−/MMP-9
−/− double-deﬁ   cient mice, the 
expression was lower (A and C, left). Error 
bars indicate mean ± SD. *, P < 0.05. After 
the ﬁ   rst postnatal week, ICAM-5 expression 
was increased in all mice, and the difference 
was not as obvious as before, although a con-
siderably lower amount was still detected in 
the double-deﬁ   cient mice (A and C, middle 
and right). In comparison, the expression of 
L1CAM gradually decreased during the post-
natal period, and little difference between the 
deﬁ  cient and WT mice was observed. *, P < 
0.05. (B) Gelatinase zymography conﬁ  rmed 
the identity of each type of mice and showed 
that the activity of MMP-2 considerably de-
creased during the postnatal development of 
the brain.JCB • VOLUME 178 • NUMBER 4 • 2007  692
deficient mice, which was not obvious in the younger mice 
(Fig. 4 B, right). Similar fi  ndings have been reported (Esparza 
et al., 2004).
Our histological analysis of the brains of MMP-2– and 
MMP-9–defi  cient mice showed that both, especially the MMP-2–
defi  cient mice, had abnormal cerebral cortical and hippocampal 
structures. The cortical layers 2–3 seemed to have increased 
number of cells (Fig. S4, available at http://www.jcb.org/cgi/
content/full/jcb.200612097/DC1). Similar fi  ndings have been 
reported in the cerebellar cortex of MMP-9–defi  cient  mice, 
which showed an abnormal accumulation of granular precursors 
in the external granular layer (Vaillant et al., 2003). We believe 
that the increased level of ICAM-5 in MMP-2–defi  cient mice is 
not due to the increased number of neurons in the cortex, be-
cause we carefully controlled the protein load per sample and 
monitored the amount of loaded actin during Western blotting.
ICAM-5 is enriched in ﬁ  lopodia and thin 
spines but not in mature mushroom spines
Dendritic spines occur in a range of sizes and in a variety of 
shapes, commonly classified as thin, stubby, and mushroom 
(Hering and Sheng, 2001; Yuste and Bonhoeffer, 2004). There is 
a strong correlation between the size of the spine head and the 
strength of the synapse, presumably related to the higher levels 
of GluRs in larger spines (Kasai et al., 2003). There is also evi-
dence that the smaller weaker spines preferentially undergo 
LTP, whereas larger spines are more stable and show less plas-
ticity (Matsuzaki et al., 2004). Such observations have led to 
the view that thin spines represent “plasticity spines” and large 
mushrooms “memory” spines (Kasai et al., 2003).
ICAM-5 was earlier found to be mainly expressed in 
dendritic fi  lopodia, and its expression inversely correlated with 
synapse maturation (Matsuno et al., 2006). To further clarify 
whether ICAM-5 is distinctively expressed in spines at differ-
ent maturation stages, we studied the dendritic protrusions of 
10–17-DIV hippocampal neurons. Such neurons contain vari-
ous dendritic protrusions, including fi  lopodia, small-head thin 
spines, and large-head mushroom spines. The dendritic fi  ne 
structures were visualized by transfection of the EGFP into the 
12-DIV neurons. The overlapping of immunostained ICAM-5 
with EGFP was measured by calculation of the Pearson’s colo-
calization effi  ciency (Fig. 5). Our result showed that ICAM-5 
was more abundantly expressed in fi  lopodia (Fig. 5 A, arrow) 
and thin spines (Fig. 5 A, arrowheads) but much less in the 
mushroom spines (Fig. 5 A, asterisks), particularly when the 
heads of the two different types of spines were compared (Fig. 
5 A). These data suggest that ICAM-5 may play a more active 
role in the “plastic” thin spines than in the more “stable” mush-
room spines.
Activation of the NRs decreases 
the colocalization of ICAM-5 with F-actin
Because we found that activation of the NRs led to dissociation 
of membrane-bound ICAM-5 from the actin cytoskeleton, it be-
came important to study ICAM-5 and F-actin distributions in 
neurons upon activation of NRs. We treated the 10-DIV hippo-
campal neurons with 5 μM NMDA and triple stained the neurons 
for the ICAM-5 cytoplasmic tail, the F-actin, and the postsyn-
aptic density (PSD) 95 protein (Fig. 6 A). Treatment of hippo-
campal neurons with NMDA resulted in reduced colocalization 
of ICAM-5 with F-actin not only along dendritic shafts  (Fig. 6, 
A and B) but also in thin and mushroom spines (Fig. 6 A, arrow-
heads and asterisks, respectively). The reduced colocalization 
of ICAM-5 with F-actin was partially counteracted by pretreat-
ment of neurons with the NR antagonist MK801 (Fig. 6, A and B). 
NMDA treatment led to a signifi  cantly increased amount of 
mushroom spines (Fig. 6 C).
Figure 5.  ICAM-5 is enriched in thin spines rather than in mushroom 
spines. (A) 12-DIV hippocampal neurons were transfected with EGFP and 
immunostained with anti–ICAM-5cp polyclonal antibody. ICAM-5 was 
strongly expressed in dendritic shafts. In the protrusions along the shaft, 
ICAM-5 was clearly located in ﬁ  lopodia (arrow) and thin spines (arrow-
heads), but much less in mushroom spines (asterisks), especially when 
the heads of the two different types of spines were compared (A). The 
colocalization of ICAM-5 with EGFP in different protrusions was ana-
lyzed and represented by Pearson’s coefﬁ  ciency (Rr). Mushroom spines 
gave the least colocalization degree, whereas thin spines and ﬁ  lopodia 
gave higher values (B). Error bars indicate mean ± SD. ***, P < 0.001. 
Bars, 10 μm.ICAM-5 CLEAVAGE BY MMPS REGULATES SPINE DEVELOPMENT • TIAN ET AL. 693
The NR-induced cleavage of ICAM-5 
is blocked by MMP inhibitors along 
dendritic shafts but not in thin spines
Because we found that NMDA and AMPA reduced anchorage 
of ICAM-5 to the actin cytoskeleton and promoted its cleavage 
through MMP-2 and -9, these facts could be the reasons for the 
exclusion of ICAM-5 from maturating spines. Therefore, it was 
important to study whether the ICAM-5 cleavage from spines, 
as a result of activation of the NRs, could be blocked by MMP 
inhibitors. For this purpose, we studied the EGFP-transfected 
17-DIV hippocampal neurons that were treated with 5 μM 
NMDA and various MMP inhibitors (Fig. 7 A). To measure the 
effects of MMP inhibitors more accurately, ICAM-5 was visu-
alized by immunostaining with a mAb that recognizes its extra-
cellular region. We found that NMDA reduced the localization of 
ICAM-5 in both the dendritic shafts and thin spines in 17-DIV 
neurons (Fig. 7 A), similar to what was observed in younger 
neurons (Fig. 6). Blocking the NRs with MK801 clearly recov-
ered the localization of ICAM-5 in both shafts and thin spines. 
When various MMP inhibitors, including the general inhibitor 
GM6001, the MMP-2/9–specifi  c peptide inhibitor CTT, and the 
inhibitor II, were applied together with NMDA, most ICAM-5 
along dendritic shafts was recovered (Fig. 7 A). However, the 
recovery of ICAM-5 in thin spines, especially in spine heads, 
was much less effi  cient by inhibition of MMPs, as compared 
with the NR antagonist MK801 (Fig. 7, A and B). This may be 
due to the fact that ICAM-5 was more vulnerable for MMPs in 
spine heads, which contain highly motile and dynamic actin fi  l-
aments, as compared with the shafts that contain a more stable 
actin cytoskeleton. We further found that pretreatment with the 
MMP-2/9 inhibitor II signifi  cantly decreased the number of 
spines induced by NMDA (Fig. 7 C).
WT and ICAM-5–deﬁ  cient neurons respond 
differently to NMDA stimulation
To further study the function of ICAM-5 in thin spines, we com-
pared the response of WT and ICAM-5
−/− hippocampal neu-
rons to NMDA stimulation. The EGFP-transfected 17-DIV fi  xed 
neurons were fi  rst immunostained for ICAM-5 and PSD95. 
ICAM-5 immunostaining verifi  ed the identity of ICAM-5
−/− neu-
rons (Fig. 8 A). In addition, the size of mushroom spines in 
ICAM-5
−/− neurons seemed to be larger than those in WT  neurons, 
Figure 6.  NMDA decreases the colocalization of ICAM-5 with F-actin in spines. (A) 10-DIV hippocampal neurons were left untreated or treated for 6 h with 
5 μM NMDA, with or without a 1-h pretreatment with the NR antagonist MK801. The neurons were then triple stained for ICAM-5 (green), F-actin (red), 
and PSD95 (blue). ICAM-5 colocalized with F-actin in dendritic ﬁ  lopodia (arrows) and thin spines (arrowheads), but much less in mushroom spines (asterisks). 
(B) The degree of colocalization between ICAM-5 and F-actin was analyzed after the above treatments. Note that NMDA signiﬁ  cantly decreased the 
colocalization of ICAM-5 with F-actin, which was partially counteracted by MK801. (C) The effects of NMDA on formation of thin and mushroom spines 
were quantiﬁ  ed. Error bars indicate mean ± SD. **, P < 0.01. Bars, 10 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  694
Figure 7.  MMP inhibitors prevent the NMDA-induced ICAM-5 cleavage in dendritic shafts but not in spines. (A) 17-DIV hippocampal neurons were trans-
fected with EGFP and either left untreated or treated for 6 h with 5 μM NMDA, with or without a 1-h pretreatment with 20 μM MK801 or MMP inhibitors. 
The neurons were then double stained for ICAM-5 by a mAb against the ectodomains of rat ICAM-5 (red) and PSD95 (blue). (B) The colocalization of 
ICAM-5 with EGFP in dendritic shafts or thin spine heads was measured. The localization of ICAM-5 in both dendritic shafts and thin spine heads (A, arrow-
heads) were signiﬁ  cantly reduced by NMDA, which was efﬁ  ciently counteracted by MK801. The MMP broad-spectrum inhibitor GM6001, in comparson 
to its negative control compound, signiﬁ  cantly blocked the NMDA-induced reduction of ICAM-5 localization in dendritic shafts. Similar effects were found 
with the MMP-2/9–speciﬁ  c inhibitors, CTT peptide, and MMP-2/9 inhibitor II. However, none of the MMP inhibitors gave substantial recovery of ICAM-5 
in thin spine heads. Furthermore, MMP-2/9 inhibitor II signiﬁ  cantly blocked the NMDA-induced formation of spines (C). The experiment was repeated three 
times with similar results. Error bars indicate mean ± SD. **, P < 0.01; ***, P < 0.001. Bars, 10 μm.ICAM-5 CLEAVAGE BY MMPS REGULATES SPINE DEVELOPMENT • TIAN ET AL. 695
which was similar to an earlier report (Matsuno et al., 2006). To 
monitor the growth of thin spines in these neurons, we studied 
the 15-DIV EGFP-transfected neurons with a time-lapse fl  uores-
cence microscope. The neurons were treated with 20 μM NMDA 
for 1 h with or without a 1-h pretreatment with MK801, and 
monitored for 1 h. We found that thin spines in WT neurons 
showed increased growth of spine heads in response to NMDA 
stimulation. In contrast, spine heads in ICAM-5
−/− neurons 
seemed to be retracting (Fig. 8 B, arrowheads). Spine numbers 
were increased in WT neurons, but not in ICAM-5
−/− neurons 
Figure 8. ICAM-5  deﬁ   ciency results in re-
traction of spine heads in response to NMDA 
stimulation.  (A) The responses of WT and 
ICAM-5
−/− hippocampal neurons to NMDA 
stimulation were compared. To verify the iden-
tity of ICAM-5–deﬁ  cient neurons, the EGFP-
transfected 17-DIV ﬁ  xed neurons of the two types 
were immunostained for ICAM-5 and PSD95. 
The size of mushroom spines in ICAM-5
−/− 
neurons seemed to be larger than those in WT 
neurons. (B) The 15-DIV EGFP-transfected neu-
rons were then monitored with a time-lapse 
ﬂ  uorescence microscope. The neurons were 
treated by 20 μM NMDA for 1 h with or with-
out a 1-h pretreatment with 20 μM MK801 
and recorded during the 1-h period of NMDA 
stimulation. Thin spines of WT neurons showed 
increased growth of spine heads in response 
to NMDA stimulation within 1 h. In contrast, 
spine heads in ICAM-5
−/− neurons seemed to 
be retracted during the 1-h treatment of NMDA 
(B, arrowheads). Intriguingly, mushroom spines 
in ICAM-5
−/− neurons respond positively toward 
NMDA stimulation, with increased size of spine 
heads (B, asterisks). (C) Spine numbers were 
increased in WT neurons but not in ICAM-5
−/− 
neurons after treatment with 5 μM NMDA for 
8 h. The experiment was repeated three times 
with similar results. Error bars indicate mean ± 
SD. *, P < 0.05; **, P < 0.01. Bars, 3 μm.JCB • VOLUME 178 • NUMBER 4 • 2007  696
after treatment with 5 μM NMDA for 8 h (Fig. 8 C). These data 
indicate that ICAM-5 is important for the motility of thin spines. 
Interestingly, we also found that mushroom spines in ICAM-5
−/− 
neurons respond positively toward NMDA stimulation, with 
increased size of spine heads (Fig. 8 B, asterisks).
sICAM-5 promotes dendritic 
ﬁ  lopodia elongation
To study functions of the sICAM-5, we cultured the EGFP-
transfected 9-DIV WT and ICAM-5
−/− neurons in the presence 
of 10 μg/ml recombinant sICAM-5 D1-4-Fc protein for 3 d. 
The neurons were then immunostained for ICAM-5 and micro-
tubule-associated protein-2 (MAP-2; Fig. 9 A). sICAM-5 D1-
4-Fc protein induced a signifi  cantly higher number of fi  lopodia 
from the WT neurons, compared with the ICAM-5
−/− neurons 
(Fig. 9, B and C). The fi  lopodial length of WT neurons also sig-
nifi  cantly increased in the presence of sICAM-5 D1-4-Fc pro-
tein, as compared with the ICAM-5
−/− neurons (Fig. 9 D).
Discussion
ICAM-5 has been shown to be gradually excluded from mature 
synapses, but the mechanism was not elucidated (Matsuno 
et al., 2006). Here, we show that activation of the NRs induced 
cleavage of ICAM-5 (Fig. 1), which evidently is mediated by 
active MMP-2 and -9 (Fig. 2). The association of ICAM-5 with 
the actin cytoskeleton was decreased in dendritic spines in re-
sponse to activation of the NRs, which affected the ICAM-5 
cleavage (Figs. 3 and 6). ICAM-5 defi  ciency led to the retrac-
tion of spine heads and a decreased number of spines in re-
sponse to NMDA stimulation (Fig. 8). sICAM-5 protein increased 
the number and length of fi  lopodia in WT neurons but not in 
ICAM-5–defi  cient neurons (Fig. 9).
Combining these data with the earlier fi  ndings on ICAM-5 
(Tian et al., 2000; Matsuno et al., 2006; Nyman-Huttunen et al., 
2006), we present a schematic model depicting the NR-mediated 
spine development in which ICAM-5 is involved (Fig. 10). 
NMDA or AMPA stimulation causes increased MMP-2 and -9 
activities in neurons and neighboring glial cells (not depicted), 
resulting in cleavage of the ectodomains of ICAM-5 from im-
mature nascent spines. The reduced membrane level of ICAM-5 
may facilitate local membrane and cytoskeleton reorganization, 
and thereby morphological remodeling of dendritic spines.
We have shown that ICAM-5 promotes dendritic elonga-
tion through homophilic interaction (Tian et al., 2000). Our cur-
rent data further indicate that the increased number and length 
of fi  lopodia from WT neurons is mediated by the homophilic 
interaction of sICAM-5 D1-4-Fc protein with membrane-bound 
Figure 9.  sICAM-5 promotes dendritic ﬁ  lopodia elongation. 9-DIV EGFP-transfected WT and ICAM-5
−/− hippocampal neurons were incubated with 
10 μg/ml soluble recombinant ICAM-5 D1-4-Fc protein or control mIgG for 72 h. The neurons were then double stained for ICAM-5 (A, red) and MAP-2 
(A, blue). Compared with mIgG control protein, sICAM-5 D1-4-Fc protein induced signiﬁ  cantly more ﬁ  lopodia from WT neurons, but not from ICAM-5
−/− 
neurons (B and C). The ﬁ  lopodial length of WT neurons, but not ICAM-5
−/− neurons, also signiﬁ  cantly increased in the presence of sICAM-5 D1-4-Fc protein (D). 
The experiment was repeated three times with similar results. Error bars indicate mean ± SD. *, P < 0.05. Bar, 10 μm.ICAM-5 CLEAVAGE BY MMPS REGULATES SPINE DEVELOPMENT • TIAN ET AL. 697
ICAM-5. These data extend our knowledge on functions of 
ICAM-5 in the context of the NR-regulated dendritic develop-
ment. Indeed, blocking the ionotropic glutamate receptors has 
been demonstrated to result in an  35% decrease in the density 
and turnover of shaft fi  lopodia, whereas focal glutamate appli-
cation leads to a 75% increase in the length of shaft fi  lopodia 
(Portera-Cailliau et al., 2003).
ICAM-5 has been postulated to be a negative regulator of 
fi  lopodia-to-spine transition (Matsuno et al., 2006). In this sense, 
the promoted cleavage by NRs implies an important mechanism 
for a transformation of immature spines toward maturation. 
Moreover, the cooperative performance of ICAM-5 together 
with the NRs and MMPs may fi  ne-tune the process of spine re-
modeling. The phenomenon that thin spines in ICAM-5
−/− neu-
rons retracted in response to NMDA treatment (Fig. 8) seems to 
be contradictory to the fact that ICAM-5
−/− neurons have even-
tually larger mature spines (Matsuno et al., 2006). As the ex-
pression of ICAM-5 is the lowest in mature spines, we suspect 
that the eventual increase in size of mature spine heads is either 
not directly ICAM-5 related or resulted from secondary effects 
of ICAM-5 defi  ciency, which needs further clarifi  cation.
We provide several lines of evidence that MMP-2 and -9 
are responsible for the proteolytic processing of ICAM-5, lead-
ing to the production of the sICAM-5. First of all, we detected a 
steady-state cleavage of ICAM-5 from the cultured primary 
neurons, which was increased by NMDA or AMPA stimula-
tion (Fig. 1). As earlier shown, MMP-9 gene expression is up-
regulated in response to extracellular stimuli, like growth factors, 
cytokines, and neurotransmitters, whereas there is lack of tran-
scriptional regulation of MMP-2 expression (Chakraborti et al., 
2003; Meighan et al., 2006; Nagy et al., 2006). These facts sug-
gest that MMP-2 is involved in the basal processing of ICAM-5 
and MMP-9 in the activity-dependent cleavage of ICAM-5. In 
addition, NMDA-induced ICAM-5 cleavage was effi  ciently pre-
vented by various MMP-2 and -9 inhibitors and siRNAs (Fig. 2). 
Abnormally high expression levels of ICAM-5 were found in 
the newborn MMP-2– or MMP-9–defi  cient mice (Fig. 4 A), 
supporting the fi  nding of involvement of MMP-2 and -9 in 
ICAM-5 proteolytic processing.
Interestingly, the difference in ICAM-5 expression be-
tween the MMP-2– or MMP-9–defi  cient mice and the WT mice 
gradually disappeared during postnatal brain development (Fig. 
4 A), which may partially be due to the decrease of MMP-2 en-
zymatic activity (Fig. 4 B) with the simultaneous increase of 
ICAM-5 expression during the later postnatal period. In contrast 
to ICAM-5, another important CAM, L1CAM, did not show 
changes in the expression levels in the MMP-2– or MMP-9–
defi  cient mice as compared with the WT mice. Furthermore, 
L1CAM showed a gradual decrease in expression during the 
postnatal period (Fig. 4 A), indicating a shift of roles between 
the two molecules during brain maturation.
An earlier report on MMP-2–defi  cient mice has shown that 
MMP-9 activity is up-regulated (Esparza et al., 2004). Here, we 
found a similar phenomenon in the brains of adult MMP-2–
defi  cient mice (Fig. 4 B). The expression of ICAM-5 in the MMP 
double-defi  cient mice was reduced during the early postnatal 
period (Fig. 4 A), which may be due to compensating effects of 
other proteases. Another possibility could be that protein synthe-
sis is defi  cient in these mice because of developmental defects.
We found that the cytoskeletal anchorage of membrane-
bound ICAM-5 was critical for controlling its proteolytic cleav-
age by MMPs. Disruption of actin fi  laments by cytochalasin D 
or latrunculin A, or deletion of the cytoplasmic tail of ICAM-5, 
signifi  cantly promoted its cleavage. Activation of the NRs re-
sulted in dissociation of ICAM-5 from the actin cytoskeleton. 
The actin cytoskeleton determines the shape, motility, and sta-
bility of dendritic spines and provides the substrates for the Rho 
family small GTPases, which are the key regulators of actin poly-
merization and spine motility (Scott and Luo, 2001; Calabrese 
et al., 2006). The NRs and GluRs have been shown to promote 
Figure 10.  Schematic model of ICAM-5 involvement in spine 
maturation and ﬁ  lopodia elongation through activation of gluta-
mate receptors. The activation of NRs or GluRs in neurons induces 
increased MMP-2 and -9 activities, which cleave the ectodomains 
of ICAM-5 from nascent spines, and results in dissociation of 
ICAM-5 from the actin cytoskeleton. The remaining CTF of ICAM-5 
may compete and disrupt the anchorage of full-length ICAM-5 to 
the actin cytoskeleton, which further promotes its cleavage from 
spines by MMPs. Reduced membrane levels of ICAM-5 may facili-
tate local membrane and cytoskeleton reorganization, which induces 
the maturation of dendritic spines. Concomitantly, the sICAM-5 
fragments produced by MMPs can bind in homophilic manner to 
the full-length ICAM-5 in the neighborhood ﬁ  lopodia and promote 
their elongation.JCB • VOLUME 178 • NUMBER 4 • 2007  698
formation and stabilization of dendritic spines, respectively, by 
inhibiting the actin-based protrusive activity from the spine 
heads (Fischer et al., 2000) and increasing the turnover time of 
dynamic actin in spines (Star et al., 2002). Inhibition of actin 
motility caused spines to round up so that spine morphology 
became more stable and regular (Fischer et al., 2000). These 
facts indicate that the cytoplasmic part of ICAM-5 participates 
in the NR-dependent morphological change of spines by exert-
ing a regulatory role on MMP-mediated ICAM-5 cleavage.
We have shown that ICAM-5 associates with the actin fi  l-
aments via α-actinin and promotes neuritic outgrowth (Nyman-
Huttunen et al., 2006). The NR subunit (NR2B) has been shown 
to interact with α-actinin (Wyszynski et al., 1997; Husi et al., 
2000). α-Actinin has been implicated in the regulation of spine 
morphology (Nakagawa et al., 2004). Therefore, it is plausible 
that the NR may directly compete with ICAM-5 for interaction 
with actin fi  laments (Fig. 10).
The role of MMPs in the normal brain development is 
gradually becoming apparent (Dzwonek et al., 2004; Luo, 2005; 
Ethell and Ethell, 2007). However, little is known concerning 
the effects of MMPs on dendritic spine development, even though 
both their ECM and non-ECM substrates in the brain have 
been found to be important for spine formation and remodeling 
(Ethell and Pasquale, 2005). Recently, MMP-7 (Bilousova et al., 
2006), MMP-9 (Meighan et al., 2006; Nagy et al., 2006), and 
MMP-24 (Monea et al., 2006) were shown to be involved in 
dendritic fi  lopodia elongation or synaptic remodeling. Particu-
larly, MMP-9–defi  cient mice show impaired LTP and behavioral 
impairments in hippocampus-dependent associative learning 
(Nagy et al., 2006), suggesting the potential importance of MMP 
on dendritic spine development.
Although mutant mice lacking individual MMPs have 
been generated (Itoh et al., 1997; Vu et al., 1998), no obvious 
defects in embryogenesis have been reported. In particular, 
MMP-2–defi  cient mice seemed to be healthy and fertile (Itoh 
et al., 1997), although they exhibited defects in bone metabo-
lism (Inoue et al., 2006). We found that MMP-2–defi  cient mice 
seemed to have an increased number of cells in the cerebral 
cortex, especially in layers 2–3 (Fig. S4). Similar fi  ndings have 
been reported in the cerebellar cortex of MMP-9–defi  cient 
mice, which showed an abnormal accumulation of granular pre-
cursors in the external granular layer (Vaillant et al., 2003). 
Thus, our fi  ndings on MMP-2–defi  cient mice deserve more careful 
and detailed study in the future.
In summary, we have defi  ned a physiological mechanism 
for the proteolytic processing of ICAM-5 by MMP-2 and -9, 
and the importance of its cleavage on regulation of dendritic 
spine development. Our results will help elucidate the functions 
of both MMPs and adhesion molecules on dendritic develop-
ment, which is still poorly understood.
Materials and methods
Reagents and antibodies
AMPA, DNQX, gelatin, MK-801, NMDA, and poly-L-lysine were obtained 
from Sigma-Aldrich. Cytochalasin D, Latrunculin A, GM6001, GM6001 
Neg. Ctrl, MMP-2/MMP-9 inhibitor II, and MMP-9 inhibitor I were ob-
tained from Calbiochem. ProMMP-2 and -9 were obtained from Roche. 
CTT and CTTW/A peptides were gifts from E. Koivunen (Division of Biochem-
istry, University of Helsinki, Helsinki, Finland; Koivunen et al., 1999).
The pAb anti–ICAM-5cp against the cytoplasmic tail of mouse 
ICAM-5 was a gift from Y. Yoshihara (Brain Science Institute/Institute of 
Physical and Chemical Research, Wako City, Japan). The pAb 1000J and 
the mAb 127E, both against the ectodomain of rat ICAM-5, were gifts from 
P. Kilgannon (ICOS Corporation, Seattle, WA). The anti-L1CAM mAb, 
anti–MAP-2 mAb, and the anti-PSD95 mAb and pAb were obtained from 
Abcam. The anti-actin pAb was obtained from Sigma-Aldrich. The pAbs 
against MMP-2 and -9 were obtained from Santa Cruz Biotechnology, Inc., 
and Chemicon, respectively. A mAb negative control was also obtained 
from Chemicon. Peroxidase-conjugated anti-mouse, anti-rabbit, and anti-
human pAbs were obtained from GE Healthcare. Alexa488-, Cy3-, or 
Cy5-conjugated anti-mouse and anti-rabbit pAbs and Cy3-conjugated 
phalloidin were obtained from Invitrogen.
Animals
MMP-2–, MMP-9–, and ICAM-5–deﬁ  cient mice were generated by gene tar-
geting (Itoh et al., 1997; Vu et al., 1998; Nakamura et al., 2001). All ani-
mals were backcrossed at least six generations into a homogenous C57BL/6 
genetic background and were bred as homozygous lines. Mice deﬁ  cient in 
both MMP-2 and -9 were obtained by intercrossing mice that were heterozy-
gous for both mutations. All experiments were approved by and performed 
according to the guidelines of the local animal ethical committee.
Cell culture
Paju-Mock, Paju-ICAM-5-ﬂ  , and Paju-ICAM-5-∆CP cell lines and hippocam-
pal neurons were prepared as described earlier (Nyman-Huttunen et al., 
2006). The CHO cell line stably expressing ICAM-5 D1- 4-Fc recombinant 
protein, a gift from J. Casasnovas (Universidad Autonoma, Madrid, Spain), 
was grown as recommended (Casasnovas et al., 1998).
Cell stimulation and sICAM-5 detection
During the 3-wk period of in vitro cultivation of hippocampal neurons, the 
culture media were replaced with HBSS with 1.8 mM CaCl2 buffer for 16 h 
on days 3, 7, 14, and 21. The 14-DIV hippocampal neurons were treated 
for 16 h with 5 μM NMDA or AMPA, with or without a 2-h pretreatment with 
20 μM MK-801 or DNQX, respectively, in HBSS/Ca
2+ buffer. When MMP 
inhibitors were applied, 20–25 μM chemical inhibitors or 100 μM peptide 
inhibitors were used together with NMDA. Paju-ICAM-5-ﬂ   and Paju-ICAM-5-
∆CP cells were incubated in serum-free culture media for 18 h. Then, 1-ml ali-
quots of the conditioned culture media were concentrated 20-fold by Vivaspin 
centrifugal concentrators (Sartorius Ltd.), and the cells were stripped off. All 
samples were suspended in Laemmli sample buffer for Western blotting.
RNA interference
9-DIV rat hippocampal neurons were transfected with 50 nM predesigned 
siRNAs against rat MMP-2, MMP-9, or negative control siRNA (Ambion) 
using Lipofectamine RNAiMAX reagent (Invitrogen) for 48 h. The culture 
media were changed into HBSS/Ca
2+ buffer for 16 h and then collected 
and concentrated for Western blotting.
Crude brain membrane preparations
Forebrains from the postnatal 1 d (n = 4), 1 wk (n = 2), and 10 wk (n = 2) 
MMP-deﬁ  cient or WT mice were homogenized with buffer containing 0.32 M 
sucrose, 10 mM Hepes, pH 7.4, 2 mM EDTA, 50 mM NaF, 1 mM Na2VO4, 
and 1× protease cocktail inhibitors, using a glass-teﬂ  on homogenizer. The 
homogenates were then centrifuged at 1,000 g, and the supernatants 
were centrifuged at 50,000 rpm to separate the membrane fractions from 
the soluble fractions. The membrane fractions were suspended in lysis buffer 
(1% Triton X-100, 50 mM Hepes, pH 7.4, 2 mM EDTA, and protease/
phosphatase inhibitors). For Western blotting, 20 μg of protein from each 
sample was suspended in Laemmli sample buffer.
Subcellular fractionations
14-DIV hippocampal neurons were either left untreated or treated with 20 μM 
NMDA for 60 min, and cells were then lysed in lysis buffer. Lysates were 
centrifuged at 5,000 rpm to get rid of the nuclear fractions, and the super-
natants were further centrifuged at 100,000 rpm for 2 h at +2°C to sepa-
rate the cytoskeletal fractions from the soluble fractions, and each sample 
was suspended in Laemmli sample buffer for Western blotting.
Recombinant protein puriﬁ  cation
Recombinant human ICAM-5 D1-4-Fc and mouse ICAM-5 D1-9-Fc proteins 
were puriﬁ   ed from cell culture supernatants by afﬁ  nity  chromatography 
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In vitro cleavage and detection of recombinant ICAM-5-Fc protein
ProMMP-2 and -9 were activated with p-aminophenylmercuric acetate and 
trypsin, respectively, and 40 ng of activated enzymes was incubated with 
2 μg ICAM-5 D1-9-Fc protein in 50 μl enzyme buffer (20 mM Hepes, 
150 mM NaCl, 0.2 mM CaCl2, 1 mM MnCl2, and 1 μM ZnCl2) at 37°C for 
18 h. 5 μl of the enzyme-substrate mixtures were suspended in sample buffer.
Western blotting
Samples were separated by 4–12% SDS-PAGE (Invitrogen) and transferred 
to nitrocellulose membranes (Whatman GmbH). After blocking, mem-
branes were incubated with anti–ICAM-5 pAb 1000J, anti–ICAM-5cp pAb, 
anti-L1CAM mAb, anti-actin pAb, or horseradish peroxidase–conjugated 
anti-human pAb, respectively, followed by peroxidase-conjugated secondary 
antibodies. Membranes were washed with TBS and 0.05% Tween 20 
after each incubation and developed with an ECL kit (GE Healthcare). 
Band intensity was quantiﬁ  ed by the software Tina 2.09c (Raytest).
Gelatinase zymography
20 μl of 60-fold–concentrated serum-free cell culture media or 50 μg of 
protein from brain membrane fractions was suspended in sample buffer 
and separated by 8% SDS−PAGE containing 0.2% gelatin. Gels were 
then washed with 2.5% Triton X-100 to remove SDS and incubated in sub-
strate buffer (50 mM Tris, pH 8, and 5 mM CaCl2) for 18 h at 37°C, fol-
lowed by staining with 0.5% Coomassie blue.
Mass spectrometry
About 1 μg ICAM-5 D1-9-Fc fragments after the MMP-2 or -9 digestion 
were separated by 4–12% SDS-PAGE (Invitrogen), silver stained, and 
analyzed in the Protein Chemistry Unit of the Institute of Biotechnology, 
University of Helsinki. The bands of interest were cut out, reduced with 
dithiothreitol, alkylated with iodoacetamide, and “in-gel” digested with 
trypsin (Sequencing Grade Modiﬁ  ed Trypsin; V5111; Promega). The re-
covered peptides were, after desalting using μ-C18 ZipTip (Millipore), 
subjected to MALDI-TOF mass spectrometric analysis. MALDI-TOF mass 
spectra for mass ﬁ  ngerprinting and MALDI-TOF/TOF mass spectra for iden-
tiﬁ  cation by fragment ion analysis were obtained using an Ultraﬂ  ex TOF/
TOF instrument (Bruker-Daltonik GmbH). Protein identiﬁ  cation with the gen-
erated data was performed using Mascot Peptide Mass Fingerprint and 
MS/MS Ion Search programs.
Flow cytometry
Paju-Mock, Paju-ICAM-5-ﬂ  , or Paju-ICAM-5-∆CP cells were incubated with 
5 μg/ml mAb TL-3 and then with Alexa488-conjugated anti-mouse pAb 
(Invitrogen). Cells were washed with PBS after each incubation. Samples 
were analyzed with FACScan and CellQuest software (Becton Dickinson).
Immunoﬂ  uorescence microscopy
Hippocampal neurons were transfected with pEGFP-N1 plasmid using Lipo-
fectamine 2000 reagent (Invitrogen) at 8–9 DIV and cultured until 12–17 
DIV. For ﬁ  lopodia elongation assay, the 9-DIV neurons were treated twice 
with 10 μg/ml of recombinant ICAM-5 D1-4-Fc protein or control mIgG for 
72 h. The 10–12-DIV neurons were then ﬁ  xed with 4% paraformaldehyde 
and permeabilized with 0.1% Triton X-100. After blocking with 2% BSA in 
PBS, neurons were stained with pAb anti–ICAM-5cp plus Alexa488- or 
Cy3-conjugated anti-rabbit IgG, Cy3-conjugated phalloidin, anti-PSD95 
mAb, or anti-MAP-2 mAb plus Cy5-conjugated anti-mouse IgG. The 17-DIV 
neurons were left untreated or treated with 5 μM NMDA with or without a 
2-h pretreatment with 20 μM MK801 or MMP inhibitors in HBSS/Ca
2+ 
buffer for 6 h. The neurons were ﬁ  xed, permeabilized, and blocked after-
ward, and stained with mAb 127E plus Cy3-conjugated anti-mouse IgG 
and anti-PSD95 pAb plus Cy5-conjugated anti-rabbit IgG. The ﬂ  uorescent 
images were taken with a confocal laser-scanning microscope under 63× 
magniﬁ  cation (TCS SP2 AOBS, HCX PL APO 63×O/1.4-0.6; Leica) using 
a charge-coupled device camera (Leica) and the LCSLite software. Four to 
ﬁ  ve neurons per sample were randomly imaged for each experiment. At 
least three proximal dendritic segments ( 60 μm per segment) were ana-
lyzed for each neuron. Dendritic ﬁ  lopodia (>2 μm long with pointy tip), 
thin spines (0.5–2.5 μm long with bulbous tip and <0.1 μm thick in neck), 
or mushroom-shaped spines (0.5–2.0 μm long and 0.3–0.6 μm wide in 
head) were quantiﬁ  ed and presented as numbers per 100 μm dendritic 
length. For live imaging, 14-DIV EGFP-transfected neurons were treated 
with 20 μM NMDA in HBSS/Ca
2+ buffer, with or without pretreatment with 
20 μM MK801 for 1 h, in 5% CO2/10% O2 at 37°C, and monitored with 
an inverted ﬂ  uorescent microscope under 60× magniﬁ  cation (IX-71; UP-
lanSApo 60×W/1.2; Olympus) using an electron multiplying charge-
coupled device camera (DV885; Andor Technology) and the TillVision 
software (Till Photonics GmbH). Images were processed with Photoshop and 
ImagePro plus. Pearson’s coefﬁ  cients were used for colocalization analysis.
Histology
Brains from 8-wk-old mice were ﬁ  xed with 4% paraformaldehyde in PBS 
and embedded in parafﬁ  n wax. Coronal parafﬁ  n sections 10 μm thick 
were cut and mounted on glass slides. Brain sections were stained with 
cresyl violet and visualized with a light microscope (IX71; Olympus). 
Images were processed with Photoshop (Adobe).
Statistical analysis
t test was used to compare different groups of data.
Online supplemental material
Fig. S1 shows that NMDA increases the expression and activities of MMP-2 
and -9. Fig. S2 shows peptide mass mapping of MMP-cleaved ICAM-5-Fc 
proteins. Fig. S3 shows ﬂ  ow cytometry analysis of transfected Paju cell lines. 
Fig. S4 shows abnormal cortical and hippocampal development in MMP-2–
deﬁ  cient mice. Online supplemental material is available at http://www
.jcb.org/cgi/content/full/jcb.200612097/DC1.
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